RESUMEN
Genetic evidence for anatomically modern humans (AMH) out of Africa before 75 thousand years ago (ka) and in island southeast Asia (ISEA) before 60 ka (93-61 ka) predates accepted archaeological records of occupation in the region. Claims that AMH arrived in ISEA before 60 ka (ref. 4) have been supported only by equivocal or non-skeletal evidence. AMH evidence from this period is rare and lacks robust chronologies owing to a lack of direct dating applications, poor preservation and/or excavation strategies and questionable taxonomic identifications. Lida Ajer is a Sumatran Pleistocene cave with a rich rainforest fauna associated with fossil human teeth. The importance of the site is unclear owing to unsupported taxonomic identification of these fossils and uncertainties regarding the age of the deposit, therefore it is rarely considered in models of human dispersal. Here we reinvestigate Lida Ajer to identify the teeth confidently and establish a robust chronology using an integrated dating approach. Using enamel-dentine junction morphology, enamel thickness and comparative morphology, we show that the teeth are unequivocally AMH. Luminescence and uranium-series techniques applied to bone-bearing sediments and speleothems, and coupled uranium-series and electron spin resonance dating of mammalian teeth, place modern humans in Sumatra between 73 and 63 ka. This age is consistent with biostratigraphic estimations, palaeoclimate and sea-level reconstructions, and genetic evidence for a pre-60 ka arrival of AMH into ISEA. Lida Ajer represents, to our knowledge, the earliest evidence of rainforest occupation by AMH, and underscores the importance of reassessing the timing and environmental context of the dispersal of modern humans out of Africa.
Asunto(s)
Cuevas , Fósiles , Migración Humana/historia , Espectroscopía de Resonancia por Spin del Electrón , Historia Antigua , Humanos , Indonesia , Luminiscencia , Bosque Lluvioso , Diente/anatomía & histología , UranioRESUMEN
This chapter has described a bioenergetic analysis of the interaction of sCD4 with an IgG1 and two IgG4 derivatives of an anti-sCD4 MAb. The MAbs have identical VH and VL domains but differ markedly in their CH and CL domains, raising the question of whether their antigen-binding chemistries are altered. We find the sCD4-binding kinetics and thermodynamics of the MAbs are indistinguishable, which indicates rigorously that the molecular details of the binding interactions are the same. We also showed the importance of using multiple biophysical methods to define the binding model before the bioenergetics can be appropriately interpreted. Analysis of the binding thermodynamics and kinetics suggests conformational changes that might be coupled to sCD4 binding by these MAbs are small or absent.
Asunto(s)
Anticuerpos Monoclonales/química , Antígenos CD4/química , Antígenos CD4/inmunología , Inmunoglobulina G/química , Sitios de Unión de Anticuerpos , Calorimetría/métodos , Rastreo Diferencial de Calorimetría/métodos , Variación Genética , Humanos , Fragmentos Fab de Inmunoglobulinas/química , Fragmentos Fc de Inmunoglobulinas/química , Cadenas Pesadas de Inmunoglobulina/química , Cadenas Ligeras de Inmunoglobulina/química , Cinética , Sustancias Macromoleculares , Microquímica/métodos , Modelos Moleculares , Conformación Proteica , Desnaturalización Proteica , Resonancia por Plasmón de Superficie/métodos , TermodinámicaRESUMEN
On the basis of sequence homologies observed between members of the E-type ATPases and the phosphate binding motifs of the actin/heat shock protein 70/sugar kinase superfamily, a human ecto-apyrase was analyzed by site-directed mutagenesis of conserved amino acids in apyrase conserved regions (ACR) I and IV. The expressed proteins were analyzed to assess the significance of these amino acids. A conserved aspartic acid residue in ACR IV was mutated to alanine, asparagine, and glutamic acid, and the relative activity and Km for ATP and ADP were determined. Mutation of this Asp 219 to Ala or Asn yielded an enzyme severely reduced in ATP hydrolyzing activity (>90%) and completely devoid of ADPase activity, along with a similar extent of inhibition of hydrolysis of other nucleoside di- and triphosphates. Interestingly, mutation of Asp 219 to Glu completely restored the ability of the enzyme to hydrolyze nucleoside triphosphates at levels above that of the wild-type enzyme, while the ability to hydrolyze nucleoside diphosphates was slightly reduced. Mutation of a second conserved aspartic acid in ACR I (Asp 62) and two invariant glycine residues in both ACR I (Gly 64) and ACR IV (Gly 221) also severely disrupted nucleotidase activity. These results demonstrate that the E-type ATPases contain the nucleoside phosphate binding domains present in the actin/heat shock protein/sugar kinase superfamily. Together with analysis of computer-predicted secondary structures, the results suggest that the ecto-ATPases and ecto-apyrases are part of, or closely related to, the actin superfamily of proteins.
Asunto(s)
Actinas/química , Adenosina Trifosfatasas/química , Adenosina Trifosfatasas/genética , Encéfalo/enzimología , Proteínas HSP70 de Choque Térmico/química , Mutagénesis Sitio-Dirigida , Fosfotransferasas (Aceptor de Grupo Alcohol)/química , Adenosina Difosfato/metabolismo , Adenosina Trifosfatasas/biosíntesis , Adenosina Trifosfato/metabolismo , Secuencia de Aminoácidos , Animales , Células COS , ADN Complementario/biosíntesis , Humanos , Hidrólisis , Datos de Secuencia Molecular , Estructura Secundaria de Proteína , TransfecciónRESUMEN
OBJECTIVE: Many patients with chronic disease use alternative therapies. Our objective was to investigate complications resulting from the use of Chinese herbal medications containing undeclared prescription drugs, and to analyze these pills. METHODS: Medical records of 5 patients with complications were reviewed. Pills from symptomatic and asymptomatic individuals were analyzed for possible content of undeclared prescription drugs. RESULTS: All pills analyzed contained mefenamic acid and diazepam. Complications related to the presence of these substances included, among others, massive gastrointestinal bleeding. CONCLUSION: Chinese herbal medications may contain undeclared prescription drugs including nonsteroidal antiinflammatory drugs and benzodiazepines.
Asunto(s)
Artritis/tratamiento farmacológico , Diazepam/aislamiento & purificación , Medicamentos Herbarios Chinos/efectos adversos , Hemorragia Gastrointestinal/inducido químicamente , Ácido Mefenámico/aislamiento & purificación , Adulto , Anciano , Enfermedad Crónica , Depresión/tratamiento farmacológico , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/química , Femenino , Humanos , Legislación de Medicamentos/normas , Masculino , Persona de Mediana Edad , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológicoRESUMEN
Increasing reports of gentamicin-resistant bacteria contaminating donor corneas and causing endophthalmitis have indicated that preservation of corneal storage media with 100 micrograms/ml of gentamicin alone needs reevaluation. We investigated the stability and possible cytotoxicity of streptomycin as a supplement to gentamicin in Optisol corneal storage medium. The combination of gentamicin and streptomycin in Optisol solution was stable at room temperature for at least 4 weeks and inhibited the growth of Staphylococcus aureus, S. epidermidis, alpha hemolytic streptococci, Streptococcus Group D, Propionibacterium acnes, Escherichia coli, and diphtheroids, but not Pseudomonas aeruginosa. The addition of vancomycin did not significantly improve the antibacterial effectiveness of the gentamicin and streptomycin combination when stored at 4 degrees C. The growth of 15 of 20 clinical ocular isolates of Ps. aeruginosa was suppressed by the gentamicin-streptomycin combination. Streptomycin in concentrations of up to 1,000 micrograms/ml did not decrease the mitotic activity of corneal endothelial cells as evaluated by the in vitro incorporation of tritiated thymidine or cause cytotoxicity. The addition of 200 micrograms/ml of streptomycin to Optisol corneal storage medium containing 100 micrograms/ml of gentamicin may significantly improve activity against gentamicin-sensitive and gentamicin-resistant contaminants.
Asunto(s)
Córnea/efectos de los fármacos , Medio de Cultivo Libre de Suero/farmacología , Gentamicinas/farmacología , Preservación de Órganos/métodos , Estreptomicina/farmacología , Anciano , Bacterias/efectos de los fármacos , Recuento de Células , Sulfatos de Condroitina , Recuento de Colonia Microbiana , Mezclas Complejas , Dextranos , Combinación de Medicamentos , Endotelio Corneal/efectos de los fármacos , Endotelio Corneal/ultraestructura , Hongos/efectos de los fármacos , Humanos , Persona de Mediana Edad , Pseudomonas aeruginosa/efectos de los fármacos , Seguridad , Vancomicina/farmacologíaRESUMEN
We have recently shown that glucose and glucosamine regulate the transcription of transforming growth factor-alpha (TGF alpha) in rat aortic smooth muscle (RASM) cells. Based on the increased potency of glucosamine compared to glucose, we hypothesized that stimulation of TGF alpha transcription by glucose is mediated through the hexosamine biosynthesis pathway. The yeast cDNA for the rate-limiting enzyme of this pathway, glutamine:fructose-6-phosphate amidotransferase (GFA), was therefore expressed in RASM cells. GFA-transfected cells showed an increase in GFA activity, exhibiting a 2.2-fold increase in the synthesis of glucosamine-6-phosphate, the first product of the hexosamine biosynthetic pathway. To test the effect of GFA overexpression on TGF alpha transcriptional activity, cells were transiently cotransfected with GFA along with a reporter plasmid containing the firefly luciferase gene under control of the TGF alpha promoter. GFA-transfected cells exhibited a glucose-dependent 2-fold increase in TGF alpha activity compared to control cells. Maximal stimulation of TGF alpha-luciferase activity by glucosamine, however, was equivalent in GFA-and control-transfected cells, confirming that the stimulation observed by both agents operated through the same pathway. This increase in TGF alpha activity was inhibited (85% at 0.5 mM glucose and 69% at 30 mM glucose) by the glutamine analog and inhibitor of GFA, 6-diazo-5-oxonorleucine (10 microM). Control studies confirmed that the increased TGF alpha-luciferase activity in the GFA-expressing cells was not an artifact of altered growth, survival, or transfection efficiency.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Regulación de la Expresión Génica/efectos de los fármacos , Glucosamina/farmacología , Glucosa/farmacología , Hexosaminas/biosíntesis , Músculo Liso Vascular/efectos de los fármacos , Factor de Crecimiento Transformador alfa/biosíntesis , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Animales , Aorta , Células Cultivadas , ADN Complementario/genética , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Glucosa/metabolismo , Glutamina-Fructosa-6-Fosfato Transaminasa (Isomerizadora)/metabolismo , Hexosaminas/fisiología , Masculino , Músculo Liso Vascular/metabolismo , Regiones Promotoras Genéticas , Ratas , Ratas Sprague-Dawley , Proteínas Recombinantes de Fusión/biosíntesis , Transfección , Tunicamicina/farmacologíaRESUMEN
A procedure for labeling rat CNS proteins in vivo which is useful for behavioral and pharmacological studies has been developed. Intraventricular administration of 35S-methionine through bilateral indwelling cannulae provided reproducible and highly specific radiolabeling of proteins from frontal cortex (FC), parietal cortex (PC), occipital cortex (OC), striatum (ST), septal nuclei (SN), amygdala (AM), hippocampus (HIP), thalamus (TH), brain stem (BS) and cerebellum (CB). Relative rates of synthesis of over 200 individual proteins were subsequently analyzed by 2DGE. Regional analysis demonstrated increased labeling of a protein of MW 28 kD and pI 6.4 in the hippocampus that was barely detectable in striatum of control rats. In heat-shocked animals, there was increased relative synthesis of the 74 kD Heat Shock Protein in both the septal nuclei and hippocampus.
Asunto(s)
Encéfalo/metabolismo , Proteínas del Tejido Nervioso/biosíntesis , Amígdala del Cerebelo/metabolismo , Animales , Tronco Encefálico/metabolismo , Cerebelo/metabolismo , Cuerpo Estriado/metabolismo , Lóbulo Frontal/metabolismo , Hipocampo/metabolismo , Cinética , Masculino , Metionina/metabolismo , Lóbulo Occipital/metabolismo , Lóbulo Parietal/metabolismo , Ratas , Ratas Endogámicas , Núcleos Septales/metabolismo , Radioisótopos de Azufre , Tálamo/metabolismoRESUMEN
Inadequate arginine intake has been suggested as an etiology for hyperammonemia in neonates on parenteral nutrition. We randomized 26 nonasphyxiated neonates to receive amino acid solutions containing either 3.6 or 10.4% of total nitrogen as arginine when intravenous nutrition (IVN) therapy was initiated. Neonates in both amino acid solution study groups were observed to have significantly elevated blood ammonia (BA) concentrations during IVN (p less than 0.01) as compared to pre-IVN levels. Blood ammonia concentrations tended to be higher in infants receiving the 3.6% arginine amino acid solution. Septic infants were at particular risk for hyperammonemia as compared to nonseptic patients (p less than 0.025). Other clinical parameters including birth weight, gestational age, oxygen requirements, enteral nutritional intake, congenital anomalies, and heart disease did not appear to be related to BA concentration.
Asunto(s)
Amoníaco/sangre , Fenómenos Fisiológicos Nutricionales del Lactante , Recién Nacido de Bajo Peso , Enfermedades del Recién Nacido/terapia , Nutrición Parenteral Total , Nutrición Parenteral , Aminoácidos/administración & dosificación , Arginina/deficiencia , Proteínas en la Dieta/administración & dosificación , Ingestión de Energía , Emulsiones Grasas Intravenosas/administración & dosificación , Humanos , Recién Nacido , Enfermedades del Recién Nacido/sangre , SolucionesRESUMEN
An extended discussion of specific therapeutic approaches and techniques with homosexual male alcohol abusers, including dealing with low self-esteem, sober sex, getting high, getting "far out" sexually, double lives, second rate relationships, social bonding, and aging. In this paper, the bias of treatment approaches is toward individualized, interpersonal, holistic eclecticism: a combination of responsibility building therapy, awareness therapy, medical and neurophysiological approaches, strategic therapy, utilization of altered states of consciousness, and attitudinal change therapy.